openPR Logo
Press release

Vasomotor Symptoms of Menopause Market 2016-2024 Industry Analysis, Trends and Forecast

08-04-2017 05:07 PM CET | Health & Medicine

Press release from: Transparency Market Research

Vasomotor Symptoms of Menopause Market 2016-2024 Industry

Global Vasomotor Symptoms of Menopause Market: Overview

Menopause is the stage during which women stop producing ovaries and there is an end of the fertile phase. It occurs in 85% of premenopausal women during their late 40s, resulting in the cessation of their menstrual cycle. Due to the cessation of menstrual flow, the production of estrogen decreases and gonadotropin increases, which gives rise to various physiological and psychological changes, called vasomotor symptoms. Vasomotor symptoms of menopause are the actions which are related to nerves and muscles that cause the blood vessels to dilate.

View Report @ http://www.transparencymarketresearch.com/vasomotor-symptoms-menopause-market.html

Vasomotor symptoms of menopause are basically a transition between two phases: perimenopause and menopause. The major vasomotor symptoms associated with menopause are listed below:

Hot flashes:
Hot flash is one of the most frequent symptoms of menopause. During this condition, women feel enormous intensity of heat accompanied with excessive sweating. Hot flashes with sweating also occur at night and the condition is termed as night sweats which disturbs the sleep pattern of an individual.

Formication:
Formication is basically a form of paresthesia which results in an abnormal skin sensation, illusion or hallucination that some insects are crawling over the skin. It causes feelings of itchiness, tingling or even burning on the skin.

Migraine:
Due to the hormonal fluctuations of menstrual cycle, migraine headaches pose a serious impediment to women undergoing menopausal phase. They are a form of recurrent headaches that can last from few hours up to three days.

Dysfunctional uterine bleeding:
Due to abrupt changes in hormonal levels, ovulation becomes inconsistent causing endometrial hyperplasia to develop and result in abnormal bleeding.

Psychological symptoms:
There are a number of psychological symptoms associated with onset of menopause such as fatigue, anxiety, irritability, mood swings, insomnia etc.

Global Vasomotor Symptoms of Menopause Market: Segmentation

There are various therapies related to vasomotor symptoms of menopause and henceforth the market can be segmented as follows:

Hormone Replacement Therapy (HRT):
HRT is a hormone therapy which is given to women whose estrogen and progesterone hormone level have dropped enormously

Selective estrogen receptor modulators (SERM):
SERMs are a type of drugs that block the effect of estrogen in the breast cells and activate the action of estrogen in other cells such as uterine cells

Gabapentin:
They are a type of medications which reduces the effect of hot flash and night sweats

Antidepressants:
Few vasomotor symptoms are relieved with the aid of antidepressants. Example: fluoxetine and venlafaxine.

Get accurate market forecast and analysis on the Vasomotor Symptoms of Menopause Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15731

The driving factors that will augment the growth of menopausal symptoms therapeutics market are introduction of new treatments and therapies in the market, increasing awareness among female patients about their health and use of non-hormonal therapies.

Global Vasomotor Symptoms of Menopause Market: Geographical Dynamics

Geographically, North America dominates the menopause therapeutics market followed by Europe. According to NutritionMD, about 40% of North American women seek treatment for menopausal symptoms. Increasing cases of menopausal symptoms and the rising need of women population to go for novel therapies are the major factors, which have driven the growth of the menopausal symptoms therapeutic market. Asia-Pacific is one of the most rapidly developing region and the prime factors that will drive the growth of menopausal symptoms therapeutics market in this region are increasing geriatric female population with menopause disorders, and a shift in preference from hormonal therapies to non-hormonal therapies that will create an opportunity for many pharmaceutical companies to develop novel technologies and therapies.

Global Vasomotor Symptoms of Menopause Market: Company Profiles

Some of the top market players of this market are Eli Lilly and Company. Procter & Gamble, Pfizer Inc., Ausio harmaceuticals, LLC, EndoCeutics, Inc., Edgemont Pharmaceuticals, LLC and many others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vasomotor Symptoms of Menopause Market 2016-2024 Industry Analysis, Trends and Forecast here

News-ID: 656822 • Views: 371

More Releases from Transparency Market Research

Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the

All 5 Releases


More Releases for Vasomotor

Vasomotor Symptoms Of Menopause Treatment Market to Register Substantial Expansi …
Eggs production process gets halted during the menopause condition, as the body produces less progesterone and estrogen the menstrual cycle slows down and eventually stops this results to various erratic symptoms. Most of the times these symptoms are manageable without clinical treatment but in many cases some form of treatment is required. According to the WHO statistics of 2015, the global sex ration is nearly 101.7, it is an indication
Vasomotor Symptoms of Menopause Treatment Market Trends & Projection to 2024
Vasomotor symptoms of menopause treatment market is expected to grow at healthy growth rate in forecast period due to rise aging population, incidences of vasomotor symptoms of menopause will mostly increase in the near future will boost the market growth. Moreover increasing awareness about medication to treat vasomotor symptoms. Many companies are currently conducting clinical trials to develop drug molecules specific for vasomotor symptoms of menopause. Request for Table of Contents
Menopausal Hot Flashes Market: Significant Increase in Vasomotor Symptoms in Wom …
The global market for menopausal hot flashes is a moderately fragmented market, in which the top eight players collectively held a share of more than 50% in 2014, states a new research study by Transparency Market Research (TMR). Novartis AG and Pfizer Inc., the top two vendors, which accounted for nearly 30% of this market in 2014, are expected to maintain their stronghold over the next few years. Pfizer is
Rising Prevalence of Menopausal Vasomotor Symptoms Remains Key Vehicle for Menop …
Menopausal Hot Flashes Market: Snapshot A substantial rise in occurrence of vasomotor symptoms or hot flashes and night sweats resulting from menopause is the single most important growth driver in the global menopausal hot flashes market. Another factor creating demand in the market is the favorable initiatives undertaken by governments and private healthcare institutes in raising awareness about women’s health. Fettering the positive effect of such growth drivers in the market
Vasomotor Symptoms of Menopause Therapeutics Pipeline Analysis, 2016
Vasomotor symptoms occur when a woman reach the state of menopause and ovaries stop producing eggs, and there is a reduction in secretion of hormones such as estrogen and progesterone. It usually occurs naturally, most often between age of 45 years to 51 years. The women feel perimenopausal transition that generally occurs prior to cessation of menstruation. During perimenopausal transition, the menstruation cycle becomes erratic, leading to irregular menses, heavy
Growth Vasomotor Symptoms of Menopause Treatment Market : 2016 - 2024
Eggs production process gets halted during the menopause condition, as the body produces less progesterone and estrogen the menstrual cycle slows down and eventually stops this results to various erratic symptoms. Most of the times these symptoms are manageable without clinical treatment but in many cases some form of treatment is required. According to the WHO statistics of 2015, the global sex ration is nearly 101.7, it is an indication